PVI
SIOX

Pura Vida Investments’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Pura Vida Investments’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-47,500
Closed -$5.68M – 99
2017
Q1 		$5.68M Buy
+47,500
New +$4.98M 1.68% 26

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Pura Vida Investments's SIOX Position: Q2 2017 in Review

Pura Vida Investments sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2017, closing a stake of 47,500 shares — an estimated $5.68M sold.

Pura Vida Investments first reported a position in SIOX in Q1 2017 and held it in 1 quarter. The position peaked at $5.68M in Q1 2017. 113 funds tracked by Wall St. Rank hold SIOX as of Q2 2017.

  • Pura Vida Investments reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Pura Vida Investments sold 47,500 Sio Gene Therapies Inc. Common Stock shares in Q2 2017, an estimated $5.68M.
  • Pura Vida Investments first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • Pura Vida Investments's Sio Gene Therapies Inc. Common Stock position peaked at $5.68M in Q1 2017.
  • 113 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2017.

Based on Pura Vida Investments's 13F filing for Q2 2017, filed 14 Aug 2017.